Marrone Bio Innovations Profit Margin

Marrone Bio Innovations posts a profit margin of -47.08% as of March 2022. That compares with -37.94% in the prior-year period — down 24.1% year over year. That is below the Materials sector average of 17.03%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Marrone Bio Innovations's profit margin was -37.94%. The latest reading is -47.08% — a 24.1% year-over-year decrease (period ending March 2022). Use the history and growth charts on this page for a longer lookback.

For Materials stocks, a profit margin near 17.03% is typical. Marrone Bio Innovations's -47.08% is lower that level. That is roughly 376.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Marrone Bio Innovations's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -47.08% as of March 2022; use YoY and peer views to separate noise from signal.

Context for MBII's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.03%), and (3) consistency with growth and profitability. This page covers the first two; Marrone Bio Innovations's other metric pages and overview cover the third.